Drive and deliver differentiated, evidence-based global HE value propositions resulting in best-in-class HTA/payer decisions, accelerated market access, and sustainable competitive advantage across ...
Drive and deliver differentiated, evidence-based global HE value propositions resulting in best-in-class HTA/payer decisions, accelerated market access, and sustainable competitive advantage across ...
Director, Global Real-World Evidence & Health Outcomes Scientist, Oncology
Upper Providence, PA · On-site
Develop a deep understanding of customers' needs, including clinicians and HTA requirements, and their acceptance of different types of evidence and impact of that evidence to their decision making.
Director, Global Real-World Evidence & Health Outcomes Scientist, Oncology
Upper Providence, PA · On-site
Develop a deep understanding of customers' needs, including clinicians and HTA requirements, and their acceptance of different types of evidence and impact of that evidence to their decision making.
Accordingly, the Director, Global HEOR, helps shape development plans, evidence strategies, and value narratives so that they align with how payers and health technology assessment (HTA) bodies make ...
Accordingly, the Director, Global HEOR, helps shape development plans, evidence strategies, and value narratives so that they align with how payers and health technology assessment (HTA) bodies make ...
Accountable for the development and delivery of innovative, timely, robust health outcomes and economic evidence to support and optimize market access, pricing, reimbursement, HTA, formulary listing ...
Accountable for the development and delivery of innovative, timely, robust health outcomes and economic evidence to support and optimize market access, pricing, reimbursement, HTA, formulary listing ...
Provide strategic input into HTA submissions and payer engagement, ensuring that evidence packages address key uncertainties and support favorable reimbursement outcomes in global markets * Drive ...
Provide strategic input into HTA submissions and payer engagement, ensuring that evidence packages address key uncertainties and support favorable reimbursement outcomes in global markets * Drive ...
Drive and deliver differentiated, evidence-based global HE value propositions resulting in best-in-class HTA/payer decisions, accelerated market access, and sustainable competitive advantage across ...
Drive and deliver differentiated, evidence-based global HE value propositions resulting in best-in-class HTA/payer decisions, accelerated market access, and sustainable competitive advantage across ...
Accordingly, the Director, Global HEOR, helps shape development plans, evidence strategies, and value narratives so that they align with how payers and health technology assessment (HTA) bodies make ...
Accordingly, the Director, Global HEOR, helps shape development plans, evidence strategies, and value narratives so that they align with how payers and health technology assessment (HTA) bodies make ...
Accountable for the development and delivery of innovative, timely, robust health outcomes and economic evidence to support and optimize market access, pricing, reimbursement, HTA, formulary listing ...
Accountable for the development and delivery of innovative, timely, robust health outcomes and economic evidence to support and optimize market access, pricing, reimbursement, HTA, formulary listing ...
Accountable for the development and delivery of innovative, timely, robust health outcomes and economic evidence to support and optimize market access, pricing, reimbursement, HTA, formulary listing ...
Accountable for the development and delivery of innovative, timely, robust health outcomes and economic evidence to support and optimize market access, pricing, reimbursement, HTA, formulary listing ...
Experience supporting HTA submissions and payer evidence generation. * Strong written and interpersonal communication skills, with an ability to present complex technical information clearly.
Experience supporting HTA submissions and payer evidence generation. * Strong written and interpersonal communication skills, with an ability to present complex technical information clearly.
Develops supplementary clinical data package in close partnership with markets and HTA statistics group for submission to HTA agencies * Supports country affiliates to understand local evidence ...
Develops supplementary clinical data package in close partnership with markets and HTA statistics group for submission to HTA agencies * Supports country affiliates to understand local evidence ...
... meet the value evidence needs of clinicians, payers, policymakers, HTA/reimbursement agencies, and health systems globally.Types of studies executed include prospective and retrospective ...
... meet the value evidence needs of clinicians, payers, policymakers, HTA/reimbursement agencies, and health systems globally.Types of studies executed include prospective and retrospective ...
S. / global payers and HTA bodies. * Advance Evidence Generation: Oversee HEOR and Real-World Evidence initiatives including cost-effectiveness analyses, budget impact models, and systematic reviews ...
S. / global payers and HTA bodies. * Advance Evidence Generation: Oversee HEOR and Real-World Evidence initiatives including cost-effectiveness analyses, budget impact models, and systematic reviews ...
Develops supplementary clinical data package in close partnership with markets and HTA statistics group for submission to HTA agencies * Supports country affiliates to understand local evidence ...
Develops supplementary clinical data package in close partnership with markets and HTA statistics group for submission to HTA agencies * Supports country affiliates to understand local evidence ...
Develops supplementary clinical data package in close partnership with markets and HTA statistics group for submission to HTA agencies * Supports country affiliates to understand local evidence ...
Develops supplementary clinical data package in close partnership with markets and HTA statistics group for submission to HTA agencies * Supports country affiliates to understand local evidence ...
... meet the value evidence needs of clinicians, payers, policymakers, HTA/reimbursement agencies, and health systems globally.Types of studies executed include prospective and retrospective ...
... meet the value evidence needs of clinicians, payers, policymakers, HTA/reimbursement agencies, and health systems globally.Types of studies executed include prospective and retrospective ...
Associate (ITC)
Boston, MA · On-site
Salary: Associate, Evidence Synthesis Medicus Economics | Boston, MA (preferred) or remote ... Implement and interpret HTA validated meta-analytic methods and indirect treatment comparisons ...
Quick apply
Associate (ITC)
Boston, MA · On-site
Salary: Associate, Evidence Synthesis Medicus Economics | Boston, MA (preferred) or remote ... Implement and interpret HTA validated meta-analytic methods and indirect treatment comparisons ...
Develop supplementary clinical data package in close partnership with markets and HTA statistics group for submission to HTA agencies. * Support country affiliates to understand local evidence ...
Develop supplementary clinical data package in close partnership with markets and HTA statistics group for submission to HTA agencies. * Support country affiliates to understand local evidence ...
Develop supplementary clinical data package in close partnership with markets and HTA statistics group for submission to HTA agencies.--Support country affiliates to understand local evidence ...
Develop supplementary clinical data package in close partnership with markets and HTA statistics group for submission to HTA agencies.--Support country affiliates to understand local evidence ...
We are now seeking a Health Economics & Payer Evidence (HEPE) Director to join Global Market Access ... Experience within payer, HTA, public health, or health policy. * Minimum of three payer-related ...
We are now seeking a Health Economics & Payer Evidence (HEPE) Director to join Global Market Access ... Experience within payer, HTA, public health, or health policy. * Minimum of three payer-related ...
Hta Evidence information
See salary details
$5.29 - $6.36
0% of jobs
$6.36 - $7.43
4% of jobs
$8.45 is the 25th percentile. Wages below this are outliers.
$7.43 - $8.50
22% of jobs
$8.50 - $9.57
23% of jobs
The median wage is $9.61 / hr.
$9.57 - $10.64
33% of jobs
$10.64 - $11.71
4% of jobs
$11.71 - $12.78
0% of jobs
$12.78 - $13.85
0% of jobs
$13.85 - $14.93
0% of jobs
$14.93 - $16
5% of jobs
$16 - $17.07
8% of jobs
$5
$10
$17
How much do hta evidence jobs pay per hour?
What are HTA Evidence specialists?
How does an HTA Evidence specialist typically collaborate with cross-functional teams during the health technology assessment process?
What is the difference between Hta Evidence vs Hta Coordinator?
| Aspect | Hta Evidence | Hta Coordinator |
|---|---|---|
| Required Credentials | Typically requires knowledge of clinical evidence, regulatory standards, and sometimes certifications in healthcare or clinical research | Requires understanding of clinical trial processes, regulatory compliance, and often certifications in project management or healthcare administration |
| Work Environment | Often involves research settings, healthcare institutions, or regulatory agencies | Primarily office-based within pharmaceutical companies, research organizations, or healthcare providers |
| Employer & Industry Usage | Used in contexts related to clinical evidence submission, regulatory approval, and health technology assessments | Commonly employed in managing clinical trial documentation, coordinating regulatory submissions, and project oversight |
Hta Evidence focuses on gathering and analyzing clinical data to support health technology assessments, while Hta Coordinator manages the coordination and documentation of clinical trials and regulatory processes. Both roles are essential in healthcare and pharmaceutical industries but serve different functions within the evidence and compliance workflow.
What are the key skills and qualifications needed to thrive in an HTA (Health Technology Assessment) Evidence role, and why are they important?

Director, Global Health Economics Lead, Oncology Business Unit
Takeda Pharmaceutical Company LimitedBoston, MA • On-site
Full-time
Dental, Vision, Life, Retirement, PTO
Posted 28 days ago
Takeda Pharmaceuticals rating
7.2
Based on 70 frontline employees who took The Breakroom Quiz
58th of 71 rated pharmaceutical
Job description
Job Description
About the role:
As a member of Takeda Oncology, your work will contribute to our bold, inspiring vision: We aspire to cure cancer. Here, you'll build a career grounded in purpose and be empowered to deliver your best. As part of the Global Health Economics team, you will report to the Head of Global Health Economics and US HEOR.
- Drive and realize value demonstration strategies for Takeda's global oncology portfolio, achieving rapid, broad patient access and delivering differentiated, evidence-based pricing through best-in-class health technology assessment (HTA; including the EU Joint Clinical Assessment [JCA]) and payer decision outcomes. Lead cross-functional integration and impact, resulting in accelerated market access, measurable commercial performance, and sustainable advantage across various assets and indications worldwide
- Lead the strategic development, execution, and continuous optimization of global health economics (HE) plans, reimbursement strategy, and evidence communication. Build and deploy best-practice tools and training to maximize adoption and impact of global HE deliverables across all regions
- Mobilize and align cross-functional and cross-regional stakeholders at all enterprise levels, including R&D, Market Access, and local operating companies (LOC), to ensure seamless integration of evidence requirements and accelerate value realization for patients and payers
- Co-lead the vision, development, and adaptive evolution of enterprise-level frameworks (e.g., Integrated Evidence Generation Plans [EGPs]), ensuring that all evidence and access strategies are fully aligned with evolving payer, HTA, and policy needs globally
- Pioneer and implement innovative digital, data science, and AI-driven health economics and outcomes research (HEOR) approaches, actively shaping Takeda's future market access strategy. Influence enterprise-level decision-making and mentor emerging leaders through formal educational and strategic thought leadership programs
- Advance Takeda's global reputation and influence by proactively shaping thought leadership at international and industry forums, policy discussions, and leading scientific consortia-building strong partnerships with HTA, payer, academic and clinical stakeholders, and elevating Takeda's position as a recognized leader in HE and value demonstration
Global Value Proposition:
- Drive and deliver differentiated, evidence-based global HE value propositions resulting in best-in-class HTA/payer decisions, accelerated market access, and sustainable competitive advantage across the oncology portfolio. Anticipate and capitalize on emerging payer and societal needs
- Direct and oversee the co-development with Global Pricing, Value & Access (PVA) and cross-functional leaders to build compelling, evolving value narratives that impact payer decisions and drive optimal patient access worldwide
- Drive strategic identification and prioritization of high-value opportunities-including new indications, lifecycle extensions, and innovative contracting models-across the portfolio
Evidence Generation:
- Provide enterprise-wide vision and impactful leadership in evidence generation to secure HTA, payer, and market access objectives, integrating payer and real-world data needs across global, regional, and local programs
- Pioneer new approaches, including digital, data science, and AI, to transform evidence generation and proactively shape Takeda's response to dynamic global value trends
- Review recommendations for advanced evidence needs (e.g., RWE, patient-centered outcomes), ensuring that internal and external partners are aligned to address emerging payer trends and requirements.
- Lead the incorporation of innovative and payer-relevant endpoints in clinical development strategies and ensure robust HTA (including JCA) readiness
HE and Value & Access Tools
- Set enterprise-wide benchmarks for scientific rigor in HEOR studies; ensure continuous innovation, external credibility, and differentiation with HTA bodies and payers
- Drive the implementation of global HE strategies and tools (Value Platforms, Dossiers, value-based contract [VBC] toolkits) and ensure consistent capability build across regions and LOCs, directly spearheading global rollouts and advanced training programs
- Co-lead the conceptualization and execution of VBC options in collaboration with Market Access and Pricing, assessing and advancing their commercial impact
- Continuously advance all HE and Market Access tools in response to dynamic evidence and payer environments
Market Access:
- Serve as enterprise expert and spokesperson for Takeda's global product value proposition-proactively engaging, influencing, and shaping both HTA policy and payer decisions to safeguard and expand market access opportunities
- Monitor and anticipate trends in the global HTA/reimbursement landscape to guide, shape, and transform Takeda's HE and access strategies at the enterprise level
Communication/Publication:
- Elevate Takeda's visibility and reputation through global HEOR communications, policy publications, and leading contributions to industry discourse
- Lead global communication strategy, translating complex technical analyses into actionable, compelling value stories for executive, payer, and policymaker audiences
Foster Superior Collaboration:
- Mobilize, empower, and align cross-functional and external networks to deliver enterprise-wide HEOR and Market Access innovation. Facilitate global knowledge sharing, mentoring, and continuous capability-building
- Cultivate and manage advanced collaborations with HE opinion leaders, vendors, and academic partners to ensure Takeda remains at the forefront of innovation and excellence in health economics
Basic Qualifications/Requirements:
- Doctorate with 7+ years of experience, Master's with 9+ years of experience or Bachelor's with 12+ years of experience in healthcare industry with direct experience in global product value proposition development (industry or consulting) and interaction with payers, HTA bodies, relevant policymakers and strong patient-centered focus
- Robust understanding of the global payer environment and in-depth understanding of ex-US payer landscape including HTA trends and guidance (e.g., NICE, CADTH, PBAC, EU JCA), along with knowledge of US Medicare (Part D), ICER in the US and trends in Emerging Markets (e.g., China) - including reimbursement methodologies, pricing/reimbursement authorities' decision-making process and current reimbursement issues
- Strong knowledge and hands on experience in health economics, health technology assessment (HTA) tools, methods and filings, SLRs, ITCs, statistical analyses and economic modelling
- Strong knowledge and understanding of clinical and epidemiological information, innovative global pricing models, all phases of drug development methods of analysis of large databases (e.g., claims data, electronic health records) and the major areas of Outcomes Research (PROs, modelling)
- Leadership - strong ability to work in a highly matrixed organization
- Strong analytical capabilities and excellent communication skills (written and oral)
- Strategic thinking and demonstrated problem solving capability
- Influencing skills (one on one and in group setting) - consensus builder with ability to effective drive decision making
- Ability to translate technical issues to non-technical experts
- 5 to 10% Domestic and/or International travel may be required
PREFERRED QUALIFICATIONS:
- Previous experience in Hematology and/or Oncology
- A combination of in-depth knowledge of Global HTA (including EU JCA) requirements and direct experience in HTA submissions
- Direct payer experience and/or experience in Market Access
- Track record of peer-reviewed publications
More about us:
At Takeda, we are transforming patient care through the development of novel specialty pharmaceuticals and best in class patient support programs. Takeda is a patient-focused company that will inspire and empower you to grow through life-changing work.
Certified as a Global Top Employer, Takeda offers stimulating careers, encourages innovation, and strives for excellence in everything we do. We foster an inclusive, collaborative workplace, in which our teams are united by an unwavering commitment to deliver Better Health and a Brighter Future to people around the world.
This position is currently classified as "hybrid" in accordance with Takeda's Hybrid and Remote Work policy
Takeda Compensation and Benefits Summary
We understand compensation is an important factor as you consider the next step in your career. We are committed to equitable pay for all employees, and we strive to be more transparent with our pay practices.
For Location:
Boston, MA
U.S. Base Salary Range:
$177,000.00 - $278,080.00
The estimated salary range reflects an anticipated range for this position. The actual base salary offered may depend on a variety of factors, including the qualifications of the individual applicant for the position, years of relevant experience, specific and unique skills, level of education attained, certifications or other professional licenses held, and the location in which the applicant lives and/or from which they will be performing the job. The actual base salary offered will be in accordance with state or local minimum wage requirements for the job location.
U.S. based employees may be eligible for short-term and/ or long-term incentives. U.S. based employees may be eligible to participate in medical, dental, vision insurance, a 401(k) plan and company match, short-term and long-term disability coverage, basic life insurance, a tuition reimbursement program, paid volunteer time off, company holidays, and well-being benefits, among others. U.S. based employees are also eligible to receive, per calendar year, up to 80 hours of sick time, and new hires are eligible to accrue up to 120 hours of paid vacation.
EEO Statement
Takeda is proud in its commitment to creating a diverse workforce and providing equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, gender expression, parental status, national origin, age, disability, citizenship status, genetic information or characteristics, marital status, status as a Vietnam era veteran, special disabled veteran, or other protected veteran in accordance with applicable federal, state and local laws, and any other characteristic protected by law.
Locations
Boston, MA
Worker Type
Employee
Worker Sub-Type
Regular
Time Type
Full time
Job Exempt
Yes
It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.
What Takeda Pharmaceuticals employees say
Pay
Benefits
Hours and flexibility
Workplace
Get the full story on Breakroom